NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects Prescription Drugs -- economics Remove constraint Subjects: Prescription Drugs -- economics Genre Technical Report Remove constraint Genre: Technical Report

Search Results

46. One percent of drugs with Medicaid reimbursement were not FDA-approved

47. Rebates for brand-name drugs in Part D substantially reduced the growth in spending from 2011 to 2015

49. Medicare Part D: CMS should monitor effects of rebates on drug coverage and spending : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

50. Changes in the list prices of prescription drugs, 2017-2023